National Academies Press: OpenBook

International Benchmarking of US Immunology Research (1999)

Chapter: Executive Summary

« Previous: Contents
Suggested Citation:"Executive Summary." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1999. International Benchmarking of US Immunology Research. Washington, DC: The National Academies Press. doi: 10.17226/9444.
×

EXECUTIVE SUMMARY

To be leaders in healthcare and to help maintain a vibrant economy, it is critical that the United States lead the world in immunological research and its clinical applications. The rapid application of immunology's fundamental discoveries has allowed them to contribute to the societal and economic well-being of our country over the past 30 years.

The Committee on Science, Engineering, and Public Policy (COSEPUP) Panel on International Benchmarking of US Immunology Research examined the leadership status of the United States in immunology. The panel was not able to assess this question in an objective way, but it used the expertise and judgment of its members and the limited information available to conclude that the United States is the world leader in immunology.

US dominance is also evident in the major subfields of immunology –cellular immunology, molecular immunology, immunogenetics, and clinical aspects of immunology. This is not a surprising result, given the level of funding of immunology and its consequent effects on the size of the US enterprise, which writes some 60% of the immunology papers published each year. However, what is of greater interest, given the size of the enterprise, is that in some parts of subfields international preeminence is more evident.

The panel also found that

  • The United States is the world leader in all the major subfields of immunology but is only among the world leaders in some specific sub-subfields.

  • Flexibility to pursue original and innovative research ideas has attracted both domestic and international human capital. Federal, state, and private funding have all contributed to a climate ripe for this innovative research.

  • Industrial interests have fostered many striking breakthroughs in immunology.

  • A scarcity of large-scale clinical trials in immunology can be attributed to shortages in funding and of qualified personnel. In addition, increasing dominance of managed care means that fewer patients are available to academic institutions for clinical trials.

  • Shifting federal and industry priorities, a potential reduction in access to domestic and foreign talent, and the increasing cost of maintaining mouse facilities could curtail US ability to capitalize on leadership opportunities.

Suggested Citation:"Executive Summary." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1999. International Benchmarking of US Immunology Research. Washington, DC: The National Academies Press. doi: 10.17226/9444.
×
This page in the original is blank.
Suggested Citation:"Executive Summary." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1999. International Benchmarking of US Immunology Research. Washington, DC: The National Academies Press. doi: 10.17226/9444.
×
Page 15
Suggested Citation:"Executive Summary." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1999. International Benchmarking of US Immunology Research. Washington, DC: The National Academies Press. doi: 10.17226/9444.
×
Page 16
Next: 1. Introduction »
International Benchmarking of US Immunology Research Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!